April 8, 2022

The Real Costs of Diabetes + Alzheimer’s

The Real Costs of Diabetes + Alzheimer’s

The access and affordability challenges that face patients with Alzheimer’s and diabetes are not uncommon. In fact, they impact all patients within the chronic disease community. Hosts Terry and Dr. Bob explore underlying issues throughout the healthcare supply chain that have hindered patient access, including rebates.

This follows the House of Representatives passing the Affordable Insulin Now Act, which would cap insulin costs at $35 a month. George Huntley, CEO of the Diabetes Leadership Council, shares what this would mean for patients, and patient correspondent CJ Walker explains how the bill fails patients who are uninsured. 

And in the wake of CMS' decision to restrict coverage of Alzheimer’s treatments to those in clinical trials, we air a conversation with Jim and Geri Taylor, who founded the Voices of Alzheimer's organization after Geri was diagnosed with Alzheimer's in 2012. 


Terry Wilcox, Executive Director, Patients Rising

Dr. Robert Goldberg, “Dr. Bob,” Co-Founder and Vice President of the Center for Medicine in the Public Interest

Kate Pecora, Field Correspondent


George Huntley, CEO of Diabetes Leadership Council 

Geri Taylor, Founder of Memory Advocate Peers, Patient advocate

Jim Taylor, Founder of Memory Advocate Peers, Patient advocate

CJ Walker, Patient Correspondent 


Diabetes Leadership Council

Who We Are | Memory Advocate Peers

House Passes Bill to Limit Cost of Insulin to $35 a Month - The New York Times

CMS Proposes Medicare Coverage Policy for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease

More than $300 Billion in Health Care Spending Goes to Middlemen. We Need Accountability.

HRSA calls for Boehringer Ingelheim to be fined over 340B contract pharmacy restrictions | Fierce Healthcare

Insulin Copay Cap Passes House Hurdle, But Senate Looks for a Broader Bill | Kaiser Health News

Walmart, Amazon up the ante in pharmacy | Supermarket News

Medicare finalizes its restrictions on new Alzheimer's drug, despite pressure from drugmakers

Need help?

The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org

Have a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent?

Drop us a line: podcast@patientsrising.org

The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.